Skip to main content
. 2021 Nov 22;9(11):1740. doi: 10.3390/biomedicines9111740

Figure 3.

Figure 3

Vaccines currently in the final phase of clinical trial. Protein subunit vaccines (9) dominate the list followed by mRNA vaccine and recombinant viral vector (3 each). Each of live attenuated, inactivated, virus like particles, and DNA vaccines are in the final phase trial.